- Research Resources
- Excellence in Science
- Excellence in Science FY24
Fiscal Year 2024 Awardees
Research is a cornerstone of MD Anderson’s quest to end cancer. The Excellence in Science program is the online showcase for the Wall of Science, our quarterly program for honoring outstanding primary research selected from among publications in top journals by MD Anderson’s world-renowned scientists.
Quarter 1 (September–November 2023)
John Heymach
New England Journal of Medicine
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
John V. Heymach, M.D., Ph.D.
Professor and Chair, Thoracic/Head and Neck Medical Oncology
David Bruton, Jr. Chair
Xiaoyin Lu and Pawel Mazur
Xiaoyin Lu, Ph.D.
Postdoctoral Fellow
Experimental Radiation Oncology
Pawel K. Mazur, Ph.D.
Assistant Professor
Experimental Radiation Oncology
Nature Biomedical Engineering
Multiplexed transcriptomic profiling of the fate of human CAR T cells in vivo via genetic barcoding with shielded small nucleotides
Krishnan Mahadevan, Raghu Kalluri and Anirban Maitra
Cancer Cell
KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
Krishnan Mahadevan, M.B.B.S., Ph.D.
Postdoctoral Fellow
Cancer Biology
Raghu Kalluri, M.D., Ph.D.
Chair and Professor, Cancer Biology
Frederick F. Becker Distinguished University Chair
Anirban Maitra, M.B.B.S.
Professor
Pathology and Translational Molecular Pathology
Marcelo Negrao
Marcelo Negrao, M.D.
Assistant Professor
Thoracic/Head and Neck Medical Oncology
Journal of Clinical Oncology
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases
Marcelo Negrao and Ferdinandos Skoulidis
Cancer Discovery
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Marcelo Negrao, M.D.
Assistant Professor
Thoracic/Head and Neck Medical Oncology
Ferdinandos Skoulidis, M.D., Ph.D.
Associate Professor
Thoracic/Head and Neck Medical Oncology
Arlene Siefker-Radtke
Arlene Siefker-Radtke, M.D.
Professor
Genitourinary Medical Oncology
New England Journal of Medicine
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
Kaile Wang and Nick Navin
Cell
Archival single-cell genomics reveals persistent subclones during DCIS progression
Kaile Wang, Ph.D.
Assistant Professor
Systems Biology
Nicholas Navin, Ph.D.
Chair and Professor
Systems Biology
The Grady F. Saunders, Ph.D. Distinguished Professorship for Molecular Biology
Michael Wang
Michael Wang, M.D., M.S.
Professor
Lymphoma-Myeloma
Puddin Clarke Endowed Professor
Journal of Clinical Oncology
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
Quarter 2 (December 2023–February 2024)
Vidhi Chandra and Florencia McAllister
Cancer Cell
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation
Vidhi Chandra, Ph.D.
Postdoctoral Fellow
Genetics
Florencia McAllister, M.D.
Associate Professor
Genetics & GI Medical Oncology
Lauren Colbert and Ann Klopp
Lauren Colbert, M.D.
Assistant Professor
Department of Radiation Oncology
Ann Klopp, M.D., Ph.D.
Professor
Department of Radiation Oncology
Cancer Cell
Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring
Eyal Gottlieb
Cell Metabolism
Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD
Eyal Gottlieb, Ph.D.
Professor
Cancer Biology
Xue Hao
Xue Hao, Ph.D.
Assistant Professor
Experimental Therapeutics
Nature
TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation
John Heymach
Nature Medicine
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
John V. Heymach, M.D., Ph.D.
Professor and Chair, Thoracic/Head and Neck Medical Oncology
David Bruton, Jr. Chair
Shubham Pant
Shubham Pant, M.D., M.B.B.S.
Professor
Gastrointestinal (GI) Medical Oncology
Nature Medicine
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Katy Rezvani and David Marin
Nature Cancer
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
Katy Rezvani, M.D., Ph.D.
Sally Cooper Murray Chair in Cancer Research
Chief, Section of Cell Therapy
Medical Director GMP and Cell Therapy Facility
Professor, Stem Cell Transplantation and Cellular Therapy
David Marin, M.D.
Professor
Stem Cell Transplantation
Haoqiang Ying
Haoqiang Ying, M.D., Ph.D.
Associate Professor
Molecular and Cellular Oncology
Science
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors